Reporting Obligations
Amebiasis is designated as a disease of public health significance and is reportable under the Ontario Health Protection and Promotion Act. Report suspect and confirmed cases within one business day to the local Health Unit.
Epidemiology
Aetiologic Agent:
Amebiasis is an enteric infection caused by Entamoeba histolytica,
a microscopic intestinal parasite excreted as cysts or trophozoites in
stools of infected people.
Clinical Presentation:
Clinical syndromes associated with E. histolytica infection
include non-invasive intestinal infection, intestinal amebiasis, ameboma
and liver abscess. Most infections are asymptomatic.
Persons with non-invasive intestinal infection may be asymptomatic or may
have non-specific intestinal tract complaints. Persons with intestinal
amebiasis (amebic colitis) generally have 1 to 3 weeks of increasingly
severe diarrhea progressing to grossly bloody dysenteric stools with lower
abdominal pain and tenesmus. Weight loss and fever may
be present. Amebic granulomata (ameboma), sometimes mistaken for carcinoma,
may occur in the wall of the large intestine in patients with intermittent
dysentery or colitis of long duration. These usually resolve with therapy
and do not require surgery. Dissemination via the bloodstream may occur and
produce abscesses of the liver, less commonly of the lung or brain.
Modes of transmission:
Mainly through ingestion of fecally contaminated food or water containing
amoebic cysts, which are relatively chlorine resistant. Cysts can survive
in moist environmental conditions for weeks to months. Transmission may
occur sexually by fecal-oral contact with a chronically ill or asymptomatic
cyst excreter, or direct rectal inoculation through colonic irrigation
devices. During the acute phase of the illness, those infected tend to shed
more trophozoites than cysts and
pose only limited danger to others because of the absence of cysts in
dysenteric stools and the fragility of trophozoites. Incubation Period:
From a few days to several months or years; commonly 2-4 weeks.
Period of Communicability:
During the period that E. hystolytica cysts are passed, which
Risk Factors/Susceptibility
-
Sexual transmission via anal-oral contact
-
Close contact with case
-
Consumption of raw unwashed produce
-
Consumption of potentially contaminated water
-
Travel outside province/country
-
Poor hand hygiene
Diagnosis & Laboratory Testing
E. hystolytica
is morphologically identical to non-pathogenic
E. dispar.
Ova and parasite (O&P) screening on stool samples preserved in Sodium
acetate-acetic acid-formalin (SAF) fixative. If positive for E.histolytia/dispar by screen, then stool antigen detection using
ELISA on unpreserved stool sample to distinguish between E. histolytica from E. Dispar.
Treatment & Case Management
Treatment is under the direction of the attending health care provider.
Provide information to patients on personal prevention measures (careful
hand hygiene after defecation, sexual contact and before preparing or
eating food) including advice to avoid public swimming pools when
symptomatic. Household members should be assessed for symptoms.
Inform patients that symptomatic cases will be excluded from conducting
activities in high-risk settings such as the food industry, healthcare, or
daycare, for 24 hours after diarrhea resolves or for 48 hours after
completion of antibiotic treatment.
Public Health will follow up as needed.
Patient Information
Additional Resources
1. Heymann, D.L. Control of Communicable Disease Manual (21th Ed.). Washington, American Public Health Association, 2022.
2.
Simcoe Muskoka HealthSTATS: Amebiasis
References
1. Ministry of Health, Infectious Diseases Protocol - Ontario Public Health Standards, 2022.